By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Solstice Neurosciences, LLC 

4010 Dupont Circle
Suite L-07
Louisville  Kentucky  40207  U.S.A.
Phone: 502-714-7800 or 650-243-4400 Fax: n/a


SEARCH JOBS








Company News
US WorldMeds, LLC Acquires Solstice Neurosciences, Inc. For $35.7 Million 8/13/2010 8:44:17 AM
Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication 2/11/2008 9:10:14 AM
Solstice Neurosciences, Inc. Announces New CEO 12/21/2007 7:15:35 AM
Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc. 10/11/2007 9:24:25 AM
Solstice Neurosciences, Inc. Presents Escalating Dose Study at International Congress in Istanbul, Turkey 6/15/2007 10:58:48 AM
Solstice Neurosciences, Inc. Announces Commercialization Agreement 5/15/2007 10:39:41 AM
Exclusive Licensing Agreement Reached Between Solstice Neurosciences, Inc. And DreamPharma Corporation For Cosmetic And Therapeutic Uses Of Myobloc(R)/NeuroBloc(R) In Korea 7/6/2006 12:14:26 PM
Solstice Neurosciences, Inc. Release: MYOBLOC(R) (Botulinum Toxin Type B) Gains Expanded Access In First Coast Service Options' Florida And Connecticut Medicare Programs 6/15/2006 12:46:54 PM
PainCare Holdings, Inc. (PRZ) Clarifies Relationship With Solstice Neurosciences, Inc. 5/11/2006 1:09:28 PM
Solstice Neurosciences, Inc. Release: Noridian Part B Carrier Grants A Single Coverage Policy For MYOBLOC Botulinum Toxin Type B And Botulinum Toxin Type A 5/2/2006 10:55:19 AM
12
//-->